F8 and autoimmune hemolytic anemia: Desmopressin (DDAVP) is not recommended in patients with AHA.21 Emicizumab is a bispecific FVIII-mimetic antibody that is registered for use in patients with inherited hemophilia either with or without inhibitory antibodies, but not for AHA.